Han-Yu Cao Hui Chen Song-Bai Liu Wen-Jie Gong Chong-Sheng Qian Tong-Tong Zhang Chao-Ling Wan Si-Man Huang Nan Xu Hai-Ping Dai Sheng-Li Xue
10.3389/fimmu.2023.1181620
Front Immunol
2023 Apr 18;14:1181620.
acute lymphoblastic leukemia blast phase blinatumomab central nervous system leukemia chronic myeloid leukemia immunotherapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/37143650/
Antineoplastic Agents / therapeutic use Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Antineoplastic Agents / therapeutic use Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy Case Reports Research Support, Non-U.S. Gov't Central Nervous System Humans Recurrence blinatumomab Antineoplastic Agents
PMC10151792
37143650
Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration
2023